- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pliant Therapeutics Inc (PLRX)
Pliant Therapeutics Inc stock price live, this page displays NASDAQ PLRX stock exchange data. View the PLRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pliant Therapeutics Inc real time stock price chart below.
What Is the Pliant Therapeutics Inc Stock Price Today?
The Pliant Therapeutics Inc stock price today is 1.66.
What Is the Stock Symbol for Pliant Therapeutics Inc?
The stock symbol for Pliant Therapeutics Inc is ""PLRX.""
What Stock Exchange Does Pliant Therapeutics Inc Trade On?
Pliant Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Pliant Therapeutics Inc a Good Stock to Buy?
Determining whether Pliant Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PLRX quote. (ISIN: US7291391057)
What Is the Pliant Therapeutics Inc Stock Price Today?
The Pliant Therapeutics Inc stock price today is 1.66.
What Is the Stock Symbol for Pliant Therapeutics Inc?
The stock symbol for Pliant Therapeutics Inc is ""PLRX.""
What Stock Exchange Does Pliant Therapeutics Inc Trade On?
Pliant Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Pliant Therapeutics Inc a Good Stock to Buy?
Determining whether Pliant Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PLRX quote. (ISIN: US7291391057)
1.66
-0.02(-1.19%)
Closed·
After Hours
1.62-0.04(-2.41%)
·
Fair Value
An estimate of a Pliant's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.54
1.71
52 wk Range
1.10
16.10
PLRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PLRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Pliant's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.541.71
52 wk Range
1.1016.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PLRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Pliant's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
4.79
Upside
+188.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Pliant Therapeutics Inc Company Profile
Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company’s lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Compare PLRX to Peers and Sector
Metrics to compare | PLRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPLRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −0.4x | −0.5x | |
PEG Ratio | 0.02 | 0.03 | 0.00 | |
Price/Book | 0.4x | 2.0x | 2.6x | |
Price / LTM Sales | - | 1.5x | 3.3x | |
Upside (Analyst Target) | 80.7% | 230.5% | 43.4% | |
Fair Value Upside | Unlock | 6.3% | 7.1% | Unlock |
Analyst Ratings
2 Buy
10 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 4.79
(+188.30% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-0.71 / -0.6595
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Pliant Trade On?
Pliant is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Pliant?
The stock symbol for Pliant is "PLRX."
What Is the Pliant Market Cap?
As of today, Pliant market cap is 103.13M.
What Is Pliant's Earnings Per Share (TTM)?
The Pliant EPS (TTM) is -3.61.
When Is the Next Pliant Earnings Date?
Pliant will release its next earnings report on 10 Nov 2025.
From a Technical Analysis Perspective, Is PLRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Pliant Stock Split?
Pliant has split 0 times.
How Many Employees Does Pliant Have?
Pliant has 171 employees.
What is the current trading status of Pliant (PLRX)?
As of 08 Aug 2025, Pliant (PLRX) is trading at a price of 1.66, with a previous close of 1.68. The stock has fluctuated within a day range of 1.54 to 1.71, while its 52-week range spans from 1.10 to 16.10.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.